Drug Trial Radar · NCT07430956
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,628
Planned (sponsor's estimate)
Start
Apr 3, 2026
Primary completion
Mar 28, 2029
Study completion Jun 26, 2029
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Feb 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can slow down or pool in one spot, which can lead to the formation of blood clots. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how effective and safe REGN7508 and REGN9933, individually, are in preventing ischemic stroke or systemic embolism in people with atrial fibrillation who cannot or may choose to not take blood thinners. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well does REGN7508 or REGN9933 lower the risk of having an ischemic stroke and/or systemic embolism compared to the placebo * How well does REGN7508 or REGN9933 lower the risk of having a major health problem affecting heart and blood circulation compared to placebo * How well does REGN7508 or REGN9933 lower the risk of death compared to placebo * How much REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the study drugs less effective or could lead to side effects)
Conditions
- Atrial Fibrillation (AF)
Interventions
REGN7508Drug
Administered per the protocol
REGN9933Drug
Administered per the protocol
PlaceboDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first occurrence of ischemic stroke or systemic embolismTime frame: Up to 36 months
- Time to first occurrence of International Society on Thrombosis and Haemostasis (ISTH) major bleedingTime frame: Up to 36 months
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
SEC Clinical Research
Dothan, Alabama · Recruiting
Sun City Clinical Research
Glendale, Arizona · Recruiting
Arkansas Cardiology P.A.
Little Rock, Arkansas · Recruiting
Mission Cardiovascular Research Institute
Fremont, California · Recruiting
National Institute of California Heart and Vein Specialists
Huntington Beach, California · Recruiting
Profound Research LLC at San Diego Cardiovascular Associates
La Jolla, California · Recruiting
Valley Clinical Trials, LLC dba Flourish Research
Northridge, California · Recruiting
Profound Research LLC at Southern California Heart Specialists
Pasadena, California · Recruiting
FOMAT - Comprehensive Cardiovascular Care
Santa Maria, California · Recruiting
Cardiology Associates Medical Group
Ventura, California · Recruiting
Interventional Cardiology Medical Group
West Hills, California · Recruiting
East Coast Institute for Research, Jacksonville
Jacksonville, Florida · Recruiting
South Florida Research Organization LLC
Medley, Florida · Recruiting
Sec Clinical Research
Pensacola, Florida · Recruiting
Cardiovascular Center of Sarasota Foundation for Research and Education
Sarasota, Florida · Recruiting
Clinical Site Partners, LLC DBA Flourish Research
Winter Park, Florida · Recruiting
Atlanta Clinical Research Centers
Atlanta, Georgia · Recruiting
NSC Research, Inc
Johns Creek, Georgia · Recruiting
Franciscan Physician Network, Indiana Heart Physicians
Indianapolis, Indiana · Recruiting
Indiana Medical Research
Merrillville, Indiana · Recruiting
Profound Research, Powers Health Medical Group - Electrophysiology
Munster, Indiana · Recruiting
Monroe Research, LLC
West Monroe, Louisiana · Recruiting
Profound Research, Cardiology and Vascular Associates (CAVA) - Bloomfield Hills
Bloomfield Hills, Michigan · Recruiting
Profound Research, Millennium Cardiology
Farmington Hills, Michigan · Recruiting
Flint Clinical Research
Flint, Michigan · Recruiting
AA Medical Research Center (MRC)
Flint, Michigan · Recruiting
Jackson Heart Clinic
Jackson, Mississippi · Recruiting
Olive Branch Family Medical Center
Olive Branch, Mississippi · Recruiting
Super Health Pharmacy
Staten Island, New York · Recruiting
Hawthorne Health, Moose Pharmacy of Concord
Concord, North Carolina · Recruiting
K&R Research LLC
Marion, Ohio · Recruiting
AnMed Health
Anderson, South Carolina · Recruiting
Monument Health Clinical Research
Rapid City, South Dakota · Recruiting
Tennessee Center for Clinical Trials
Tullahoma, Tennessee · Recruiting
PharmaTex Research
Amarillo, Texas · Recruiting
PanAmerican Clinical Research
Brownsville, Texas · Recruiting
Southwest Family Medicine Associates
Dallas, Texas · Recruiting
East Texas Cardiology
Houston, Texas · Recruiting
Synergy Group Medical,LLC
Houston, Texas · Recruiting
Synergy Groups Medical
Houston, Texas · Recruiting
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.